AVR 1.08% $13.14 anteris technologies ltd

Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-92

  1. 2,243 Posts.
    lightbulb Created with Sketch. 132
    So glad someone picked up on it - they mention it twice - the studies main endpoint was to see if it was safe!

    second - to if the tech works - which is programming the t cells to to do the work - which clearly they they did and with a bit of tweaking can (possibly) achieve the result that satisfies the creation of a vaccine be that 92% and above who knows?

    i think this has bee missed, as your eyes are drawn into the high beams of the result 58% and 80%
    makes FDA approval a given (logical using bodies own cells) , now they just need to tweak the program

    i am not in this for the Vax as most of you know but this to me is extremely positive - assessing further details in 2017
    Last edited by 1mission: 19/10/16
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$13.14
Change
0.140(1.08%)
Mkt cap ! $277.7M
Open High Low Value Volume
$13.20 $13.50 $13.14 $559.5K 42.05K

Buyers (Bids)

No. Vol. Price($)
2 1180 $13.00
 

Sellers (Offers)

Price($) Vol. No.
$13.35 500 1
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.